INCYTE CORP (1INCY.MI) Stock Fundamental Analysis

BIT:1INCY • US45337C1027

95.3 EUR
+13.26 (+16.16%)
Last: Jan 7, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

Taking everything into account, 1INCY scores 7 out of 10 in our fundamental rating. 1INCY was compared to 78 industry peers in the Biotechnology industry. 1INCY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1INCY is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, 1INCY could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 1INCY had positive earnings in the past year.
  • 1INCY had a positive operating cash flow in the past year.
  • Of the past 5 years 1INCY 4 years were profitable.
  • 1INCY had a positive operating cash flow in 4 of the past 5 years.
1INCY.MI Yearly Net Income VS EBIT VS OCF VS FCF1INCY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • 1INCY's Return On Assets of 18.78% is amongst the best of the industry. 1INCY outperforms 92.77% of its industry peers.
  • 1INCY's Return On Equity of 25.55% is amongst the best of the industry. 1INCY outperforms 92.77% of its industry peers.
  • The Return On Invested Capital of 1INCY (18.88%) is better than 96.39% of its industry peers.
  • 1INCY had an Average Return On Invested Capital over the past 3 years of 6.87%. This is below the industry average of 11.66%.
  • The last Return On Invested Capital (18.88%) for 1INCY is above the 3 year average (6.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.78%
ROE 25.55%
ROIC 18.88%
ROA(3y)5.08%
ROA(5y)5.23%
ROE(3y)6.75%
ROE(5y)6.82%
ROIC(3y)6.87%
ROIC(5y)N/A
1INCY.MI Yearly ROA, ROE, ROIC1INCY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 24.69%, 1INCY belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
  • 1INCY's Profit Margin has declined in the last couple of years.
  • 1INCY has a better Operating Margin (26.10%) than 84.34% of its industry peers.
  • 1INCY's Operating Margin has declined in the last couple of years.
  • 1INCY's Gross Margin of 93.47% is amongst the best of the industry. 1INCY outperforms 87.95% of its industry peers.
  • 1INCY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.1%
PM (TTM) 24.69%
GM 93.47%
OM growth 3Y-50.23%
OM growth 5Y-33.03%
PM growth 3Y-71.07%
PM growth 5Y-48.24%
GM growth 3Y-0.87%
GM growth 5Y-0.53%
1INCY.MI Yearly Profit, Operating, Gross Margins1INCY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • 1INCY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1INCY has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 1INCY has less shares outstanding
  • 1INCY has a worse debt/assets ratio than last year.
1INCY.MI Yearly Shares Outstanding1INCY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
1INCY.MI Yearly Total Debt VS Total Assets1INCY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • 1INCY has an Altman-Z score of 9.72. This indicates that 1INCY is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of 1INCY (9.72) is better than 86.75% of its industry peers.
  • The Debt to FCF ratio of 1INCY is 0.03, which is an excellent value as it means it would take 1INCY, only 0.03 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.03, 1INCY belongs to the top of the industry, outperforming 97.59% of the companies in the same industry.
  • 1INCY has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • 1INCY's Debt to Equity ratio of 0.01 is amongst the best of the industry. 1INCY outperforms 83.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 9.72
ROIC/WACC2.13
WACC8.87%
1INCY.MI Yearly LT Debt VS Equity VS FCF1INCY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • 1INCY has a Current Ratio of 3.20. This indicates that 1INCY is financially healthy and has no problem in meeting its short term obligations.
  • 1INCY has a Current ratio of 3.20. This is in the better half of the industry: 1INCY outperforms 66.27% of its industry peers.
  • 1INCY has a Quick Ratio of 3.13. This indicates that 1INCY is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 1INCY (3.13) is better than 67.47% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.13
1INCY.MI Yearly Current Assets VS Current Liabilites1INCY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • 1INCY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 575.79%, which is quite impressive.
  • 1INCY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.21% yearly.
  • The Revenue has grown by 18.09% in the past year. This is quite good.
  • Measured over the past years, 1INCY shows a quite strong growth in Revenue. The Revenue has been growing by 14.46% on average per year.
EPS 1Y (TTM)575.79%
EPS 3Y-21.7%
EPS 5Y-14.21%
EPS Q2Q%111.21%
Revenue 1Y (TTM)18.09%
Revenue growth 3Y12.41%
Revenue growth 5Y14.46%
Sales Q2Q%20.05%

3.2 Future

  • 1INCY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.11% yearly.
  • The Revenue is expected to grow by 1.31% on average over the next years.
EPS Next Y428.71%
EPS Next 2Y146.91%
EPS Next 3Y91%
EPS Next 5Y29.11%
Revenue Next Year18.23%
Revenue Next 2Y14.6%
Revenue Next 3Y12.92%
Revenue Next 5Y1.31%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1INCY.MI Yearly Revenue VS Estimates1INCY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
1INCY.MI Yearly EPS VS Estimates1INCY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.23, which indicates a rather expensive current valuation of 1INCY.
  • Based on the Price/Earnings ratio, 1INCY is valued cheaply inside the industry as 86.75% of the companies are valued more expensively.
  • 1INCY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.68.
  • 1INCY is valuated correctly with a Price/Forward Earnings ratio of 13.76.
  • Based on the Price/Forward Earnings ratio, 1INCY is valued cheaply inside the industry as 96.39% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, 1INCY is valued rather cheaply.
Industry RankSector Rank
PE 17.23
Fwd PE 13.76
1INCY.MI Price Earnings VS Forward Price Earnings1INCY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1INCY is valued cheaper than 83.13% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1INCY indicates a rather cheap valuation: 1INCY is cheaper than 89.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.16
EV/EBITDA 13.62
1INCY.MI Per share data1INCY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of 1INCY may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1INCY's earnings are expected to grow with 91.00% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y146.91%
EPS Next 3Y91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1INCY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INCYTE CORP

BIT:1INCY (1/7/2026, 7:00:00 PM)

95.3

+13.26 (+16.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-28
Earnings (Next)02-09
Inst Owners105.27%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap18.71B
Revenue(TTM)4.81B
Net Income(TTM)1.19B
Analysts75.63
Price Target89.04 (-6.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.23%
Min EPS beat(2)4.72%
Max EPS beat(2)33.74%
EPS beat(4)3
Avg EPS beat(4)10.09%
Min EPS beat(4)-10.01%
Max EPS beat(4)33.74%
EPS beat(8)3
Avg EPS beat(8)-1.54%
EPS beat(12)6
Avg EPS beat(12)-3.05%
EPS beat(16)7
Avg EPS beat(16)-8.28%
Revenue beat(2)2
Avg Revenue beat(2)5.08%
Min Revenue beat(2)3.45%
Max Revenue beat(2)6.72%
Revenue beat(4)4
Avg Revenue beat(4)3.8%
Min Revenue beat(4)1.09%
Max Revenue beat(4)6.72%
Revenue beat(8)5
Avg Revenue beat(8)1.4%
Revenue beat(12)7
Avg Revenue beat(12)0.24%
Revenue beat(16)9
Avg Revenue beat(16)0.48%
PT rev (1m)7.85%
PT rev (3m)32.6%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)26.48%
EPS NY rev (1m)0%
EPS NY rev (3m)14.17%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)6.25%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)9.12%
Valuation
Industry RankSector Rank
PE 17.23
Fwd PE 13.76
P/S 4.52
P/FCF 18.16
P/OCF 17.37
P/B 4.67
P/tB 4.97
EV/EBITDA 13.62
EPS(TTM)5.53
EY5.8%
EPS(NY)6.93
Fwd EY7.27%
FCF(TTM)5.25
FCFY5.51%
OCF(TTM)5.49
OCFY5.76%
SpS21.1
BVpS20.39
TBVpS19.19
PEG (NY)0.04
PEG (5Y)N/A
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 18.78%
ROE 25.55%
ROCE 25.17%
ROIC 18.88%
ROICexc 45.7%
ROICexgc 52.73%
OM 26.1%
PM (TTM) 24.69%
GM 93.47%
FCFM 24.87%
ROA(3y)5.08%
ROA(5y)5.23%
ROE(3y)6.75%
ROE(5y)6.82%
ROIC(3y)6.87%
ROIC(5y)N/A
ROICexc(3y)24.04%
ROICexc(5y)N/A
ROICexgc(3y)30%
ROICexgc(5y)N/A
ROCE(3y)9.17%
ROCE(5y)N/A
ROICexgc growth 3Y-34.92%
ROICexgc growth 5Y-33.44%
ROICexc growth 3Y-36.33%
ROICexc growth 5Y-29.08%
OM growth 3Y-50.23%
OM growth 5Y-33.03%
PM growth 3Y-71.07%
PM growth 5Y-48.24%
GM growth 3Y-0.87%
GM growth 5Y-0.53%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.02
Cap/Depr 59.08%
Cap/Sales 1.13%
Interest Coverage 250
Cash Conversion 92.81%
Profit Quality 100.71%
Current Ratio 3.2
Quick Ratio 3.13
Altman-Z 9.72
F-Score7
WACC8.87%
ROIC/WACC2.13
Cap/Depr(3y)83.51%
Cap/Depr(5y)185.09%
Cap/Sales(3y)1.73%
Cap/Sales(5y)3.66%
Profit Quality(3y)367.72%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)575.79%
EPS 3Y-21.7%
EPS 5Y-14.21%
EPS Q2Q%111.21%
EPS Next Y428.71%
EPS Next 2Y146.91%
EPS Next 3Y91%
EPS Next 5Y29.11%
Revenue 1Y (TTM)18.09%
Revenue growth 3Y12.41%
Revenue growth 5Y14.46%
Sales Q2Q%20.05%
Revenue Next Year18.23%
Revenue Next 2Y14.6%
Revenue Next 3Y12.92%
Revenue Next 5Y1.31%
EBIT growth 1Y6374.01%
EBIT growth 3Y-44.05%
EBIT growth 5Y-23.34%
EBIT Next Year366.76%
EBIT Next 3Y85.61%
EBIT Next 5Y26.81%
FCF growth 1Y106.03%
FCF growth 3Y-24.05%
FCF growth 5Y-17.01%
OCF growth 1Y97.88%
OCF growth 3Y-23.52%
OCF growth 5Y-13.95%

INCYTE CORP / 1INCY.MI FAQ

Can you provide the ChartMill fundamental rating for INCYTE CORP?

ChartMill assigns a fundamental rating of 7 / 10 to 1INCY.MI.


What is the valuation status of INCYTE CORP (1INCY.MI) stock?

ChartMill assigns a valuation rating of 8 / 10 to INCYTE CORP (1INCY.MI). This can be considered as Undervalued.


Can you provide the profitability details for INCYTE CORP?

INCYTE CORP (1INCY.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for 1INCY stock?

The financial health rating of INCYTE CORP (1INCY.MI) is 9 / 10.